國立虎尾科技大學 |

Endocannabinoids and lipid mediators in brain functions

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Endocannabinoids and lipid mediators in brain functions/ edited by Miriam Melis.
other author:	Melis, Miriam.
Published:	Cham :Springer International Publishing : : 2017.,
Description:	xii, 372 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Cannabinoids - Physiological effect. -
Online resource:	http://dx.doi.org/10.1007/978-3-319-57371-7
ISBN:	9783319573717

Endocannabinoids and lipid mediators in brain functions
Endocannabinoids and lipid mediators in brain functions[electronic resource] /edited by Miriam Melis. - Cham :Springer International Publishing :2017. - xii, 372 p. :ill., digital ;24 cm.

- The Endocannabinoid System in Leptin-Driven Changes of Orexinergic Signalling Under Physiological and Pathological Conditions -- How CB1 Receptor Activity and Distribution Contribute to Make the Male and Female Brain Different Towards Cannabinoid-Induced Effects -- Endocannabinoids, Stress, and Negative Affect -- Cell-Autonomous Endocannabinoid Production Shapes Polarized and Dynamic Distribution and Signaling Patterns of Cannabinoid CB1 Receptors in Neurons -- Endocannabinoid-Dependent Synaptic Plasticity in Striatum -- Lipid Mediators in the Regulation of Emotions, Memory and Cognitive Functions -- The Endocannabinoid System in Prefrontal Synaptopathies -- Cannabinoids and Mitochondria -- Endocannabinoids and Lipid Mediators in Brain Function -- Endocannabinoid Signaling in Reward and Addiction: From Homeostasis to Pathology -- Roles of N-Acylethanolamines in Brain Functions and Neuropsychiatric Diseases -- Mast Cells and Glia as Targets for the Anandamide Congener Palmitoylethanolamide, and Anti-Inflammatory and Neuroprotective Lipid-Signaling Molecule.

The science of cannabinoids is 50 years old. These past years provided a remarkable and constant number of breakthroughs, showing that the signaling mediated by endocannabinoids and lipid mediators impacts almost every function of the body. Indeed, this represents a special field of research, which allows tackling the complexity of biological functions, and provides potential therapeutic frameworks for a plethora of diseases. The number of exciting discoveries brought up to the scientific community almost on a daily basis highlights the importance of an updated volume on this topic. Particularly, given that potential therapeutic benefits of cannabis and cannabinoids are currently under heavy analysis in many Countries worldwide. Hence, the main objective of this book is to explore not only some of the many functions of endocannabinoids (and lipid mediators) in physiological control of networks at a cellular and molecular level, but also to extend this knowledge for potential use of cannabinoids and/or drugs regulating endocannabinoid levels in vivo as therapeutic target(s) in neurological and neuropsychiatric disorders. In this book new findings and ideas about the endocannabinoid system and its roles as neuronal circuit modulator related to human brain pathologies characterized by alterations in neuroplasticity will be highlighted. Endocannabinoid roles in key systems controlling appetite, pain, learning and memory, as well as sleep and stress responses will be presented. In addition, pathological processes associated with changes in endocannabinoid signaling will be discussed in the context of anxiety, autism, depression and addiction. This book will provide an excellent background to researchers looking for extending their areas of interest, and to newcomers in the field.

ISBN: 9783319573717

Standard No.: 10.1007/978-3-319-57371-7doiSubjects--Topical Terms:

583584
Cannabinoids
--Physiological effect.

LC Class. No.: QP801.C27

Dewey Class. No.: 615.7827

Endocannabinoids and lipid mediators in brain functions
LDR:03827nam a2200313 a 4500 001 885123
003 DE-He213
005 20170531021649.0
006 m d
007 cr nn 008maaau
008 180530s2017 gw s 0 eng d
020 $a 9783319573717 $q (electronic bk.)
020 $a 9783319573694 $q (paper)
024 7 $a 10.1007/978-3-319-57371-7 $2 doi
035 $a 978-3-319-57371-7
040 $a GP $c GP
041 0 $a eng
050 4 $a QP801.C27
072 7 $a PSAN $2 bicssc
072 7 $a MED057000 $2 bisacsh
082 0 4 $a 615.7827 $2 23
090 $a QP801.C27 $b E56 2017
245 0 0 $a Endocannabinoids and lipid mediators in brain functions $h [electronic resource] / $c edited by Miriam Melis.
260 $a Cham : $c 2017. $b Springer International Publishing : $b Imprint: Springer,
300 $a xii, 372 p. : $b ill., digital ; $c 24 cm.
505 0 $a - The Endocannabinoid System in Leptin-Driven Changes of Orexinergic Signalling Under Physiological and Pathological Conditions -- How CB1 Receptor Activity and Distribution Contribute to Make the Male and Female Brain Different Towards Cannabinoid-Induced Effects -- Endocannabinoids, Stress, and Negative Affect -- Cell-Autonomous Endocannabinoid Production Shapes Polarized and Dynamic Distribution and Signaling Patterns of Cannabinoid CB1 Receptors in Neurons -- Endocannabinoid-Dependent Synaptic Plasticity in Striatum -- Lipid Mediators in the Regulation of Emotions, Memory and Cognitive Functions -- The Endocannabinoid System in Prefrontal Synaptopathies -- Cannabinoids and Mitochondria -- Endocannabinoids and Lipid Mediators in Brain Function -- Endocannabinoid Signaling in Reward and Addiction: From Homeostasis to Pathology -- Roles of N-Acylethanolamines in Brain Functions and Neuropsychiatric Diseases -- Mast Cells and Glia as Targets for the Anandamide Congener Palmitoylethanolamide, and Anti-Inflammatory and Neuroprotective Lipid-Signaling Molecule.
520 $a The science of cannabinoids is 50 years old. These past years provided a remarkable and constant number of breakthroughs, showing that the signaling mediated by endocannabinoids and lipid mediators impacts almost every function of the body. Indeed, this represents a special field of research, which allows tackling the complexity of biological functions, and provides potential therapeutic frameworks for a plethora of diseases. The number of exciting discoveries brought up to the scientific community almost on a daily basis highlights the importance of an updated volume on this topic. Particularly, given that potential therapeutic benefits of cannabis and cannabinoids are currently under heavy analysis in many Countries worldwide. Hence, the main objective of this book is to explore not only some of the many functions of endocannabinoids (and lipid mediators) in physiological control of networks at a cellular and molecular level, but also to extend this knowledge for potential use of cannabinoids and/or drugs regulating endocannabinoid levels in vivo as therapeutic target(s) in neurological and neuropsychiatric disorders. In this book new findings and ideas about the endocannabinoid system and its roles as neuronal circuit modulator related to human brain pathologies characterized by alterations in neuroplasticity will be highlighted. Endocannabinoid roles in key systems controlling appetite, pain, learning and memory, as well as sleep and stress responses will be presented. In addition, pathological processes associated with changes in endocannabinoid signaling will be discussed in the context of anxiety, autism, depression and addiction. This book will provide an excellent background to researchers looking for extending their areas of interest, and to newcomers in the field.
650 0 $a Cannabinoids $x Physiological effect. $3 583584
650 0 $a Cannabinoids $x Receptors. $3 583585
650 0 $a Brain. $3 562499
650 1 4 $a Biomedicine. $3 593880
650 2 4 $a Neurosciences. $3 593561
650 2 4 $a Psychopharmacology. $3 644799
650 2 4 $a Pharmacology/Toxicology. $3 593882
700 1 $a Melis, Miriam. $3 1142120
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-57371-7
950 $a Biomedical and Life Sciences (Springer-11642)